Hamm-Alvarez indicated that tear cathepsin S activity was found to be significantly increased in patients with SS compared to patients with non-SS DE and healthy controls, and suggested that it may be a simple and non-invasive biomarker for the diagnosis and evaluation of SS [24]. This evidence concerns the gene CTSS and synovial sarcoma.